Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients

INTRODUCTION: Cardiovascular diseases are the leading cause of death worldwide. The combination of statins and cholesterol-absorption inhibitors promotes the decrease in risk factors, such as high concentrations of LDL (low-density lipoproteins). The aim of the study was to evaluate changes in the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Saldaña, Joel, Padilla-Padilla, Francisco, Cardona-Muñoz, Ernesto G., Romero-Antonio, Yulia, Arguedas-Núñez, María Marcela, Sander-Padilla, José G., Martínez-Muñoz, Alberto, Lugo-Sánchez, Laura A., Rodríguez-Vazquez, Ileana C., González-Canudas, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482503/
https://www.ncbi.nlm.nih.gov/pubmed/36124294
http://dx.doi.org/10.1155/2022/9464733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482503/
https://www.ncbi.nlm.nih.gov/pubmed/36124294
http://dx.doi.org/10.1155/2022/9464733

Ejemplares similares